Isoflavones stimulate estrogen receptor-mediated core histone acetylation

Biochemical and Biophysical Research Communications

Volumn 317, Issue 1, 2004, Pages 259-264

  Hong, Tao ^a,b   Nakagawa, Takeya ^a   Pan, WeiJun ^c   Kim, Mi Young ^d   Kraus, W Lee ^d   Ikehara, Tsuyoshi ^a   Yasui, Kiyoshi ^a   Aihara, Hitoshi ^a   Takebe, Minoru ^b   Muramatsu, Masami ^e   Ito, Takashi ^a,e  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nichimo Co Ltd   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Department of Obstetrics Gynecology   (United States)

^e SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

AglyMax; Daidzein; Equol; Estradiol; Estrogen receptor; Genistein; Histone acetylation

Indexed keywords

CORE PROTEIN; DAIDZEIN; EQUOL; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE H2A; HISTONE H2B; HISTONE H3; ISOFLAVONE DERIVATIVE; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN P300; TAMOXIFEN;

ACETYLATION; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; CELL LINE; DROSOPHILA; ESTRADIOL; ESTROGEN ANTAGONISTS; GENISTEIN; HISTONE ACETYLTRANSFERASES; HISTONES; ISOFLAVONES; NUCLEAR PROTEINS; NUCLEAR RECEPTOR COACTIVATOR 2; RECEPTORS, ESTROGEN; RECOMBINANT PROTEINS; SPODOPTERA; TAMOXIFEN; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 12144290788     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.041     Document Type: Article

References (30)

1. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β Endocrinology. 139:1998;4252-4263.
2. Juul A. The effects of oestrogens on linear bone growth. Hum. Reprod. Update. 7:2001;303-313.
3. Grodstein F., Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog. Cardiovasc. Dis. 38(3):1995;199-210. (Review).
4. McEwen B.S., Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 20:1999;279-307.
5. Setchell K.D., Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129:1999;758S-767S. (Review).
6. Brandi M.L. Natural and synthetic isoflavones in the prevention and treatment of chronic diseases. Calcif. Tissue Int. 61:1997;S5-S8. (Review).
7. Messina M.J. Legumes and soybeans: overview of their nutritional profiles and health effects. Am. J. Clin. Nutr. 70:1999;439S-450S. (Review).
8. Doerge D.R., Chang H.C. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777:2002;269-279. (Review).
9. Rafii F., Davis C., Park M., Heinze T.M., Beger R.D. Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Arch. Microbiol. 180:2003;11-16.
10. Wiseman H., O'Reilly J.D., Adlercreutz H., Mallet A.I., Bowey E.A., Rowland I.R., Sanders T.A. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72:2000;395-400.
11. Latonnelle K., Fostier A., Le Menn F., Bennetau-Pelissero C. Binding affinities of hepatic nuclear estrogen receptors for phytoestrogens in rainbow trout (Oncorhynchus mykiss) and Siberian sturgeon (Acipenser baeri). Gen. Comp. Endocrinol. 129:2002;69-79.
12. Ruiz-Larrea M.B., Mohan A.R., Paganga G., Miller N.J., Bolwell G.P., Rice-Evans C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 26:1997;63-70.
13. Setchell K.D., Brown N.M., Lydeking-Olsen E. The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J. Nutr. 132:2002;3577-3584. (Review).
14. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852.
15. Mizzen C.A., Allis C.D. Linking histone acetylation to transcriptional regulation. Cell. Mol. Life Sci. 54:1998;6-20. (Review).
16. Kraus W.L., Kadonaga J.T. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev. 12:1998;331-342.
17. Sadovsky Y., Webb P., Lopez G., Baxter J.D., Fitzpatrick P.M., Gizang-Ginsberg E., Cavailles V., Parker M.G., Kushner P.J. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol. Cell. Biol. 15:1995;1554-1563.
18. Hardy S., Brand M., Mittler G., Yanagisawa J., Kato S., Meisterernst M., Tora L. TATA-binding protein-free TAF-containing complex (TFTC) and p300 are both required for efficient transcriptional activation. J. Biol. Chem. 277:2002;32875-32882.
19. Misra P., Qi C., Yu S., Shah S.H., Cao W.Q., Rao M.S., Thimmapaya B., Zhu Y., Reddy J.K. Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation. J. Biol. Chem. 277:2002;20011-20019.
20. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
21. Kim M.Y., Hsiao S.J., Kraus W.L. A role for coactivators and histone acetylation in estrogen receptor α-mediated transcription initiation. EMBO J. 20:2001;6084-6094.
22. Ito T., Bulger M., Pazin M.J., Kobayashi R., Kadonaga J.T. ACF, an ISWI-containing and ATP-utilizing chromatin assembly and remodeling factor. Cell. 90:1997;145-155.
23. Ohtake F., Takeyama K., Matsumoto T., Kitagawa H., Yamamoto Y., Nohara K., Tohyama C., Krust A., Mimura J., Chambon P., Yanagisawa J., Fujii-Kuriyama Y., Kato S. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature. 423:2003;545-550.
24. Lamberts S.W., van den Beld A.W., van der Lely A.J. The endocrinology of aging. Science. 278:1997;419-424. (Review).
25. Wolf O.T., Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm. Behav. 41:2002;259-266.
26. Wakatsuki A., Okatani Y., Ikenoue N., Fukaya T. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women. Circulation. 106:2002;1771-1776.
27. Morton M.S., Arisaka O., Miyake N., Morgan L.D., Evans B.A. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J. Nutr. 132:2002;3168-3171.
28. Nikander E., Kilkkinen A., Metsa-Heikkila M., Adlercreutz H., Pietinen P., Titinen A., Ylikorkala O. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet. Gynecol. 101:2003;1213-1220.
29. Monroe D.G., Johnsen S.A., Subramaniam M., Getz B.J., Khosla S., Riggs B.L., Spelsberg T.C. Mutual antagonism of estrogen receptors α and β and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines. J. Endocrinol. 176:2003;349-357.
30. Routledge E.J., White R., Parker M.G., Sumpter J.P. Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) α and ERβ J. Biol. Chem. 275:2000;35986-35993.